Acenocoumarol as an alternative anticoagulant in a patient with warfarin-related nephropathy

被引：5

作者：

Behera, Sapan Kumar ^{[1
]}

Xavier, Alphienes Stanley ^{[1
]}

Selvarajan, Sandhiya ^{[1
]}

Munuswamy, Hemachandren ^{[2
]}

Haridasan, Satish ^{[3
]}

Srinivas, Bheemanathi Hanuman ^{[4
]}

机构：

[1] JIPMER, Dept Clin Pharmacol, Pondicherry 605006, India

[2] JIPMER, Dept Cardiothorac & Vasc Surg, Pondicherry, India

[3] JIPMER, Dept Nephrol, Pondicherry, India

[4] JIPMER, Dept Pathol, Pondicherry, India

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2018年 / 84卷 / 05期

关键词：

D O I：

10.1111/bcp.13541

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Adverse EventWarfarin-related nephropathy. Drug ImplicatedWarfarin. The PatientA 31-year-old female, managed with warfarin for rheumatic heart disease with atrial fibrillation. Evidence that Links the Drug to the EventThere were no alternative causes of nephropathy that could have caused the adverse event in this patient. ManagementShifting the drug from warfarin to acenocoumarol. MechanismDifference in renal elimination between warfarin and acenocoumarol. Implication for TherapyClinicians should be aware of this rare adverse effect of warfarin, and acenocoumarol can be considered as an alternative therapy for this condition. Hypotheses to be TestedFurther prospectively designed studies are needed to consider acenocoumarol as an alternative therapy in warfarin-related nephropathy.

引用

页码：1068 / 1071

页数：4

共 50 条

[41] Double whammy: anticoagulant-related nephropathy with leukocytoclastic vasculitis due to warfarin
Gaurav Bhandari
Vaibhav Tiwari
Anurag Gupta
Pallav Gupta
Vinant Bhargava
Manish Malik
Ashwani Gupta
Anil Kumar Bhalla
D. S. Rana
CEN Case Reports, 2022, 11 : 154 - 158
[42] Double whammy: anticoagulant-related nephropathy with leukocytoclastic vasculitis due to warfarin
Bhandari, Gaurav
Tiwari, Vaibhav
Gupta, Anurag
Gupta, Pallav
Bhargava, Vinant
Malik, Manish
Gupta, Ashwani
Bhalla, Anil Kumar
Rana, D. S.
CEN CASE REPORTS, 2022, 11 (01) : 154 - 158
[43] Association Between Patient Knowledge of Anticoagulation, INR Control, and Warfarin-Related Adverse Events
Rahmani, Poupak
Guzman, Charlotte
Kezouh, Abbas
Blostein, Mark
Kahn, Susan R.
JOURNAL OF PHARMACY TECHNOLOGY, 2016, 32 (04) : 150 - 159
[44] Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate
Brodsky, Sergey V.
Nadasdy, Tibor
Rovin, Brad H.
Satoskar, Anjali A.
Nadasdy, Gyongyi M.
Wu, Haifeng M.
Bhatt, Udayan Y.
Hebert, Lee A.
KIDNEY INTERNATIONAL, 2011, 80 (02) : 182 - 190
[45] WARFARIN RELATED NEPHROPATHY
Joshi, Sumendra
Bhardwaj, Rahul
Kamalia, Sonal
AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (05) : A61 - A61
[46] Assessment of the coding accuracy of warfarin-related bleeding events
Delate, Thomas
Jones, Aubrey E.
Clark, Nathan P.
Witt, Daniel M.
THROMBOSIS RESEARCH, 2017, 159 : 86 - 90
[47] INR >2 predisposes to warfarin-related ICH enlargement
Reactions Weekly, 2003, 945 (1) : 4 - 4
[48] WARFARIN-RELATED HEMORRHAGE AFTER VALVE-REPLACEMENT
MONTALESCOT, G
THOMAS, D
GROSGOGEAT, Y
AMERICAN HEART JOURNAL, 1988, 116 (06) : 1649 - 1650
[49] Hypertension as a risk factor for warfarin-related intracranial bleeding
Berwaerts, J
Dijkhuizen, RS
Jeffers, TA
Robb, OJ
Webster, J
JOURNAL OF HYPERTENSION, 2000, 18 : S8 - S8
[50] The Risk of Warfarin-Related Bleeds and Supratherapeutic INR Associated with the Use of Complementary and Alternative Medicines: A Longitudinal Analysis
Shalansky, Stephen
Lynd, Larry
Richardson, Kathryn
Ignaszewski, Andrew
Kerr, Charles
CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2008, 61 (01): : 84 - 84

← 1 2 3 4 5 →